http://rdf.ncbi.nlm.nih.gov/pubchem/patent/OA-11950-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_c76ecadad74a1a35270b3e3a34d60f37
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D405-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-55
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D401-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-06
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-44
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D401-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D-
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D401-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4422
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-40
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K-
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4025
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D405-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D405-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P3-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-48
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4439
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P-
filingDate 2000-03-20-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_bb0ed7398022c2833ec7ae97cdc2f5f8
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6b0b13faa289da92f9e9f6d98e037f4b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_fe2701a4c9e7860b497bd6af679dbc58
publicationDate 2006-04-13-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber OA-11950-A
titleOfInvention Mutual prodrugs of amlodipine and atorvastatin.
abstract This invention relates to mutual prodrugs of amlodipine and atorvastatin and to pharmaceutical compositions thereof. This invention also relates to methods of treating angina pectoris, atherosclerosis, and hypertension and hyperlipidemia in a mammal using those prodrugs and compositions. This invention also relates to methods of managing cardiac risk in a mammal, including humans, presenting with symptoms of cardiac risk by administering those prodrugs and compositions.
priorityDate 1999-05-27-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID12325849
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID4485
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419534378
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID449233333
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ9PS30
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID1003
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID54454
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419527089
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID454611257
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419506595
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ9Y4Z0
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID422983385
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP47851
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID7371
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ8R1I2
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID448850249
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP09472
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID2162
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419506502
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP31886
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID4510
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID411550721
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP24393
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID457460012
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419506484
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419534614
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID62754
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID27661
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419555446
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID422584570
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP63152
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID54687
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP63153
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP01295
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458393769
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID425013245
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419525482
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID60496
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419496926
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID60822
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID60823
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419506158
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID4616
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID21933717
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6883
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID456171974
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP08989
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID21977402
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419534941
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP07492
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID53232
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ863C3

Total number of triples: 85.